Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.1%

2 terminated out of 49 trials

Success Rate

90.5%

+4.0% vs benchmark

Late-Stage Pipeline

12%

6 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (20)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed19
Unknown13
Recruiting11
Terminated2
Active Not Recruiting2
Withdrawn1

Trial Success Rate

90.5%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (49)

Showing 20 of 20 trials
NCT05350969Phase 2CompletedPrimary

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

NCT04968808Not ApplicableRecruitingPrimary

Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

NCT05198791Phase 2RecruitingPrimary

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

NCT07409441Not Yet RecruitingPrimary

Korea Acute Myocardial Infarction Registry

NCT07181317RecruitingPrimary

WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up

NCT03412435RecruitingPrimary

Asan Medical Center Myocardial Infarction Registry

NCT04420624Phase 2TerminatedPrimary

COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

NCT03155022Not ApplicableCompletedPrimary

Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction

NCT05759078Phase 4RecruitingPrimary

Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion

NCT04753749Not ApplicableCompletedPrimary

Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

NCT06318481Phase 3Completed

TADCLOT- a Double Blind Randomized Controlled Trial

NCT07008391Not ApplicableRecruiting

High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS

NCT04167904CompletedPrimary

Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction

NCT04626882Not ApplicableActive Not RecruitingPrimary

Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)

NCT06141252Not ApplicableCompleted

Benefit of Hypothermia in OHCA Complicating AMI

NCT06252168RecruitingPrimary

Registry of Acute Myocardial Infarction

NCT06698341RecruitingPrimary

UNdeRstAnding Novel Variants in AcutE MyocardiaL Infarction in Young Adults

NCT05043610Phase 3CompletedPrimary

MSCs for Prevention of MI-induced HF

NCT05077683Phase 3CompletedPrimary

Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF

NCT03809689Not ApplicableTerminatedPrimary

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Scroll to load more

Research Network

Activity Timeline